Scarica l'app Stockscreener
30.46
7.33%
-2.41
Dopo l'orario di chiusura:
30.46
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$32.87
Aprire:
$32.56
Volume 24 ore:
348.62K
Relative Volume:
1.41
Capitalizzazione di mercato:
$620.18M
Reddito:
$71.10M
Utile/perdita netta:
$-6.38M
Rapporto P/E:
-25.36
EPS:
-1.2009
Flusso di cassa netto:
$-39.84M
1 W Prestazione:
-15.69%
1M Prestazione:
+13.91%
6M Prestazione:
+2.91%
1 anno Prestazione:
+36.84%
Intervallo 1D:
$30.34
$32.69
Intervallo di 1 settimana:
$30.34
$36.77
Portata 52W:
$20.23
$39.70
Assembly Biosciences Inc Stock (ASMB) Company Profile
Nome
Assembly Biosciences Inc
Settore
Industria
Telefono
(833) 409-4583
Indirizzo
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Compare ASMB vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
30.46 | 669.25M | 71.10M | -6.38M | -39.84M | -1.2009 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-24 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-08-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-03-25 | Iniziato | Guggenheim | Buy |
| 2024-09-20 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-09-13 | Iniziato | H.C. Wainwright | Neutral |
| 2021-09-02 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | Downgrade | Jefferies | Buy → Hold |
| 2020-10-19 | Iniziato | Truist | Buy |
| 2019-10-16 | Iniziato | Mizuho | Buy |
| 2018-11-19 | Iniziato | Leerink Partners | Outperform |
| 2018-10-08 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | Iniziato | Robert W. Baird | Outperform |
| 2018-04-13 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | Iniziato | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | Iniziato | Jefferies | Buy |
| 2017-05-30 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Assembly Biosciences Inc Borsa (ASMB) Ultime notizie
Assembly Bio schedules a live webcast for Sept. 16 - Stock Titan
Oil Surge Continues on Escalating Middle East Crisis: 4 Defensive Picks - TradingView
Why is Assembly Biosciences stock surging today? By Investing.com - Investing.com Australia
Assembly Bio opts into 40% U.S. profit share for herpes drug By Investing.com - Investing.com South Africa
Why is Assembly Biosciences stock surging today? - Investing.com
Assembly Biosciences (ASMB) Shares U.S. Development Costs and Pr - GuruFocus
Assembly Bio stock gains after exercising Gilead profit option By Investing.com - Investing.com South Africa
Assembly Bio stock gains after exercising Gilead profit option - Investing.com
Assembly Bio opts into 40% U.S. profit share for herpes drug - Investing.com Canada
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program - The Manila Times
Assembly Biosciences exercises profit share option with Gilead for HSV program - TipRanks
A $75 million Gilead payment is due in Q4, while Assembly Bio expects cash to fund operations into 2029. - Stock Titan
Zacks.com featured highlights include EuroDry, RCM, Assembly Biosciences, Delcath and National Energy Services - Yahoo Finance
Wall Street Analysts See a 35.71% Upside in Assembly Biosciences (ASMB): Can the Stock Really Move This High? - Yahoo Finance
Assembly Biosciences Price Target Announced at $52.00/Share by UBS - Moomoo
Should You Buy Assembly Biosciences (ASMB) After Golden Cross? - Yahoo Finance
How Assembly Biosciences Inc. (ASMB) Affects Rotational Strategy Timing - Stock Traders Daily
Here's Why Momentum in Assembly Biosciences (ASMB) Should Keep going - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Assembly Biosciences (ASMB) - The Globe and Mail
ASMB Maintained by Mizuho -- Price Target Lowered to $45 - GuruFocus
ASMB Initiates Coverage On UBS -- Price Target Announced at $52. - GuruFocus
Assembly Biosciences price target raised to $53 from $45 at Mizuho - TipRanks
UBS initiates Assembly Biosciences stock with buy rating on antiviral platform - Investing.com Nigeria
UBS initiates Assembly Biosciences stock with buy rating on antiviral platform By Investing.com - Investing.com South Africa
Mizuho lowers Assembly Biosciences stock price target to $45 - Investing.com
Assembly Biosciences Inc (ASMB) Stock Price, Quote, News & History - Benzinga
Price to earnings forward of Assembly Biosciences, Inc. – NASDAQ:ASMB - TradingView
Certain Stock Options of Assembly Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 21-AUG-2026. - marketscreener.com
Wall Street Analysts Think Assembly Biosciences (ASMB) Could Surge 40.66%: Read This Before Placing a Bet - Zacks Investment Research
Q3 EPS Forecast for Assembly Biosciences Raised by Analyst - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Shares Gap UpShould You Buy? - MarketBeat
HC Wainwright Issues Negative Estimate for ASMB Earnings - MarketBeat
Assembly Biosciences (ASMB) Slides 8.92% to $30.01 as Key Support Comes into FocusFundamental Weighted - vinanet.vn
Assembly Biosciences (NASDAQ:ASMB) Earns "Buy" Rating from HC Wainwright - MarketBeat
H.C. Wainwright reiterates Assembly Biosciences stock rating at buy - Investing.com
H.C. Wainwright reiterates Assembly Biosciences stock rating at buy By Investing.com - Investing.com India
ASMB Reiterated by HC Wainwright & Co. -- Maintains Price Target at $50 - GuruFocus
Assembly Biosciences reports Q2 EPS (20c), consensus (52c) - TipRanks
Assembly Biosciences: Gilead Advancements For GS-1179 And ABI-6250 Is A Bullish Signal - Seeking Alpha
Assembly Biosciences, Inc. (NASDAQ:ASMB) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Assembly Biosciences (ASMB) sees Paradigm BioCapital report 7.8% ownership stake - Stock Titan
Why (ASMB) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Assembly Biosciences (NASDAQ:ASMB) Trading Up 8.2% on Strong Earnings - MarketBeat
Assembly Biosciences, Inc.: Revenue and Earnings Analysts Forecasts Revisions | ASMB | US0453962070 - marketscreener.com
Assembly Biosciences earnings beat by $0.53, revenue topped estimates - Investing.com Nigeria
Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates - The Manila Times
Assembly Biosciences (ASMB) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Assembly Biosciences (NASDAQ:ASMB) Issues Quarterly Earnings Results, Beats Expectations By $0.52 EPS - MarketBeat
Assembly Biosciences (ASMB) boosts cash to $320M and narrows loss - Stock Titan
Assembly Biosciences: Q2 Earnings Snapshot - AOL.com
Assembly Biosciences: Cash Runway Projected Into 2029 >ASMB - Moomoo
Assembly Biosciences Inc Azioni (ASMB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):